Michael Isakoff, MD

Division Head, Center for Cancer and Blood Disorders | Director, Sarcoma Program | Director, Reid R. Sacco Adolescent and Young Adult Cancer Program | Medical Director, Connecticut Children’s Clinical Trials Unit

Michael Isakoff, MD, is the Division Head of the Center for Cancer and Blood Disorders and the Hartford Whalers’ Endowed Chair in Children’s Cancer. Dr. Isakoff’s expertise includes bone sarcoma, soft tissue sarcoma, rare tumors, and clinical trial development. 

Education

New York University School of Medicine

Residency

Yale-New Haven Children's Hospital

Fellowship

Boston Children’s Hospital and Dana-Farber Cancer Institute

American Board of Pediatrics - Pediatric Hematology-Oncology
American Board of Pediatrics - Pediatrics

Professor of Pediatrics, University of Connecticut School of Medicine

  • View Dr. Isakoff's bibliography
  • Reed DR, Metts J, Pressley M, Fridley BL, Hayashi M, Isakoff MS, Loeb DM, Makanji R, Roberts RD, Trucco M, Wagner LM, Alexandrow MG, Gatenby RA, Brown JS. An evolutionary framework for treating pediatric sarcomas. Cancer. 2020 Jun 1;126(11)2577-2587. doi: 10.1002/cncr.32777. Epub 2020 Mar 16. PubMed PMID: 32176331.
  • Spraker-Perlman HL, Barkauskas DA, Krailo MD, Meyers PA, Schwartz CL, Doski J, Gorlick R, Janeway KA, Isakoff MS. Factors influencing survival after recurrence in osteosarcoma: A report from the Children’s Oncology Group. Pediatr Blood Cancer. 2019 Jan;66(1):e27444. doi: 10.1002/pbc.27444. Epub 2018 Sep 25. PubMed PMID: 30255612; PMCID: PMC6249072.
  • Isakoff MS, Goldsby R, Villaluna D, Krailo MD, Hingorani P, Collier A, Morris CD, Kolb EA, Doski JJ, Womer RB, Gorlick R, Janeway KA. A phase II study of eribulin in recurrent or refractory osteosarcoma: A report from the Children’s Oncology Group. Pediatr Blood Cancer. 2018 Oct 30:e27524. doi: 10.1002/pbc.27524. [Epub ahead of print] PubMed PMID: 30378256.
  • Reed DR, Hayashi M, Wagner L, Binitie O, Steppan DA, Brohl AS, Shinohara ET, Bridge JA, Loeb DM, Borinstein SC, Isakoff MS. Treatment pathway of bone sarcoma in children, adolescents, and young adults. Cancer. 2017 Jun 15;123(12):2206-2218. doi: 10.1002/cncr.30589. Epub 2017 Mar 21. Review. PubMed PMID: 28323337.
  • Isakoff MS, Bielack SS, Meltzer P, Gorlick R. Osteosarcoma: Current Treatment and a Collaborative Pathway to Success. J Clin Oncol. 2015 Sep 20;33(27):3029-35.doi: 10.1200/JCO.2014.59.4895. Epub 2015 Aug 24. Review. PubMed PMID: 26304877.

Member of the Children’s Oncology Group (COG) Voting Body Steering Committee (VBSC)

Locations Where I See Patients

Connecticut Children’s Specialty Care Center – Danbury

105 Newtown Road
Danbury, CT06810
United States

Exterior view of Connecticut Children's Medical Center in Hartford

Connecticut Children’s Medical Center – Hartford

282 Washington Street
Hartford, CT06106
United States

Exterior of 505 Farmington Avenue

Connecticut Children's Specialty Care and Surgery Center – Farmington

505 Farmington Avenue
Farmington, CT06032
United States